Global Dry Powder Inhaler Device Market Growth 2023-2029

Global Dry Powder Inhaler Device Market Growth 2023-2029

A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.

LPI (LP Information)' newest research report, the “Dry Powder Inhaler Device Industry Forecast” looks at past sales and reviews total world Dry Powder Inhaler Device sales in 2022, providing a comprehensive analysis by region and market sector of projected Dry Powder Inhaler Device sales for 2023 through 2029. With Dry Powder Inhaler Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dry Powder Inhaler Device industry.

This Insight Report provides a comprehensive analysis of the global Dry Powder Inhaler Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dry Powder Inhaler Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Dry Powder Inhaler Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dry Powder Inhaler Device and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dry Powder Inhaler Device.

The global Dry Powder Inhaler Device market size is projected to grow from US$ 769.5 million in 2022 to US$ 1088.8 million in 2029; it is expected to grow at a CAGR of 1088.8 from 2023 to 2029.

GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, etc. are the key players in the global Dry Powder Inhaler Device market. Top 4 took up more than 30% of the global market.

From the view of region, USA have a larger consumption market share which account for about 35% of total share. Europe hold a market share of about 25%. In addition, Asia Pacific is also play important role in Global market.

Dry Powder Inhaler Device main application area is Asthma This sector hold a market share of over 80%. Then followed by the COPD.

According to the Segmentation of types, all the market of Dry Powder Inhaler Device can be divided as follows: Multi-dose, Single-dose.

This report presents a comprehensive overview, market shares, and growth opportunities of Dry Powder Inhaler Device market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

Single Dose

Multi Dose

Segmentation by application

Asthma

COPD

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

GlaxoSmithKline

AstraZeneca

Boehringer Ingelheim

Chiesi

Cipla

3M

Hovione

Mannkind

Mylan

Novartis

Schering/Merck

Teva

Vectura

Key Questions Addressed in this Report

What is the 10-year outlook for the global Dry Powder Inhaler Device market?

What factors are driving Dry Powder Inhaler Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Dry Powder Inhaler Device market opportunities vary by end market size?

How does Dry Powder Inhaler Device break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.